Dentsply International, Inc. (XRAY) Misses Q4 EPS by 1c, Offers FY12 EPS Guidance
Tweet
Share
E-mailGet Alerts XRAY Hot Sheet
Price: $11.38 -0.44%
EPS Growth %: -36.0%
Financial Fact:
Interest expense: 8.4M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -36.0%
Financial Fact:
Interest expense: 8.4M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Dentsply International, Inc. (NASDAQ: XRAY) reported Q4 adjusted EPS of $0.51, $0.01 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $738 million versus the consensus estimate of $723 million.
Dentsply International, Inc. sees FY2012 EPS of $2.22-$2.30, versus the consensus of $2.28.
For earnings history and earnings-related data on Dentsply International, Inc. (XRAY) click here.
Dentsply International, Inc. sees FY2012 EPS of $2.22-$2.30, versus the consensus of $2.28.
For earnings history and earnings-related data on Dentsply International, Inc. (XRAY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Morgan Stanley Downgrades Peloton Interactive (PTON) to Underweight
- Computacenter Plc. (CCC:LN) PT Raised to GBP60 at JPMorgan
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
